Daniel Katz, Committee Chair
General Manager at Bristol-Myers Squibb
Committee Members:
-
Mati Gil, Head of Government Affairs Corporate & International Markets, Teva Pharmaceuticals
-
Dror Harats, CEO, Vascular Biogenics Ltd.
-
Tali Rosin, Hear of Public Affairs & Policy Manager , Pfizer Pharmaceuticals Israel
-
Yoel Lipschitz, VP Regulatory Affairs & Market Access, Medison Pharma
-
Avi Buskila, CEO, SAREL Logistics Solutions & Producrs for Advanced Medicin Ltd.
-
Orna Steinberger, CEO, Boehringer Ingelheim Israel Ltd.
-
Tina Meerry Melusyan, CEO, Sanofi Ltd.
-
Tammy Altarac, Managing Director, MSD Israel
-
Dalit Hazan, VP Regulatory Affair, PolyPid Ltd.
-
Avraham Raz, CEO, Eli Lilly Israel Ltd.
-
Ron Babecoff, CEO, BiondVax Pharmaceuticals Ltd.
-
Yaron Itzhari, CEO, Medronic Trading
- Avi Danziger, CEO, Roche Pharmaceuticals (Israel) Ltd.